Related Experiment Video
Updated: Jun 21, 2026

11:17
Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
Published on: February 10, 2014
11.8K
A highly sensitive sensor for carcinoembryonic antigen based on AlGaN/GaN high-electron-mobility transistors
WeiSun Huang1, Shengjie Hu2, Xuecheng Jiang2
1Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, Jiangsu, People's Republic of China.
Nanotechnology
|May 3, 2023
Summary
Researchers developed a novel, label-free biosensor for detecting carcinoembryonic antigen (CEA), a key lung cancer biomarker. This cost-effective and rapid method offers improved medical diagnostics for lung cancer detection.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Diagnostics
Background:
- Carcinoembryonic antigen (CEA) is a validated serum biomarker for lung cancer.
- Accurate and early detection of lung cancer is crucial for effective treatment.
- Existing diagnostic methods may lack sensitivity, speed, or cost-effectiveness.
Purpose of the Study:
- To develop a simple, label-free method for detecting carcinoembryonic antigen (CEA).
- To utilize AlGaN/GaN high-electron-mobility transistors for enhanced biosensing capabilities.
- To establish a highly sensitive and rapid detection platform for lung cancer biomarkers.
Main Methods:
- Immobilization of CEA antibodies onto the sensing region of AlGaN/GaN high-electron-mobility transistors.
- Fabrication of label-free biosensors for specific CEA recognition.
- Testing the biosensor performance in phosphate buffer solution to determine detection limits.
Main Results:
- The developed biosensor demonstrated label-free detection of CEA.
- High sensitivity was achieved with a detection limit of 1 fg/mL.
- The AlGaN/GaN based biosensor showed specific recognition of CEA.
Conclusions:
- The novel biosensor offers a promising approach for sensitive and rapid CEA detection.
- This technology presents advantages in integration, miniaturization, and cost-effectiveness.
- The developed method has potential for future applications in lung cancer medical diagnostics.

